Eidos治疗(EIDX)

122.21 0.00 0.0%

今开:0.0昨收:122.21
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4.74931561E9

Eidos治疗的热门评论

Eidos治疗(EIDX)2020-08-07 04:40

$Eidos治疗(EIDX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-037811 Act: 34 Size: 543 KB 网页链接查看全文

Eidos治疗(EIDX)2020-08-11 07:30

$Eidos治疗(EIDX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-021954 Size: 7 KB 网页链接查看全文

Eidos治疗(EIDX)2020-08-08 05:05

$Eidos治疗(EIDX)$ 8-K Current report, items 5.02, 7.01, 8.01, and 9.01 Accession Number: 0001193125-20-213106 Act: 34 Size: 205 KB 网页链接查看全文

Eidos治疗(EIDX)2020-08-06 07:55

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-021565 Size: 12 KB 网页链接查看全文

Replix锐璞美股2019-06-27 14:04

$Adaptive生物技术(ADPT)$ /$BridgeBio Pharma(BBIO)$ -明天IPO,ADPT定价$20, BBIO定价 $17, 从定价来看两家公司都比较受市场欢迎。流通股的数量都差不多,123M左右。Viking Global 都是两家的大股东。ADPT走的是当下热点Computational Biology/Machine Learning。BBIO走的是VC模式,持有$Eidos治...查看全文

Eidos治疗(EIDX)2020-07-10 08:46

$Eidos治疗(EIDX)$ 内部交易: 2020-07-07,See Remarks,Fox Jonathan C ,卖出,5000普通股, $50.00查看全文

Eidos治疗(EIDX)2020-07-16 03:31

【异动】$Eidos治疗(EIDX)$ 03:31涨幅达7.24%,现价50.20美元查看全文

Eidos治疗(EIDX)2020-07-15 22:44

【异动】$Eidos治疗(EIDX)$ 22:44涨幅达4.04%,现价48.70美元查看全文

Eidos治疗(EIDX)2020-07-10 04:15

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-018813 Size: 5 KB 网页链接查看全文

Eidos治疗(EIDX)2020-07-07 23:41

【异动】$Eidos治疗(EIDX)$ 23:41涨幅达4.38%,现价51.04美元查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的最新评论

Eidos治疗(EIDX)2021-01-27 05:27

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017733 Size: 29 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-003286 Size: 7 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-017696 Act: 33 Size: 22 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017697 Act: 33 Size: 23 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017698 Act: 33 Size: 23 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017699 Act: 33 Size: 23 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-26 22:06

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017128 Act: 34 Size: 33 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-26 21:51

$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-21-017109 Act: 34 Size: 381 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-26 21:51

$Eidos治疗(EIDX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000105 Act: 34 Size: 2 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-21 05:27

$Eidos治疗(EIDX)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001193125-21-012447 Act: 34 Size: 208 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的公告

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017733 Size: 29 KB 网页链接

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-003286 Size: 7 KB 网页链接

$Eidos治疗(EIDX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-017696 Act: 33 Size: 22 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017697 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017698 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017699 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017128 Act: 34 Size: 33 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-21-017109 Act: 34 Size: 381 KB 网页链接

$Eidos治疗(EIDX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000105 Act: 34 Size: 2 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001193125-21-012447 Act: 34 Size: 208 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15